Landmark Study Targets Repair and Regeneration for MS Patients
The Multiple Sclerosis Research Center of New York (MSRCNY) and the International Cellular Medicine Society (ICMS) jointly announced today the ICMS Institutional Review Board's (IRB) approval of the first study to use autologous brain-like or neural stem cells for multiple sclerosis.
"We are entering a whole new world of possibilities for our patients" said Dr. Saud A. Sadiq, Neurologist and Director of the MSRCNY. "This initial stem cell treatment strategy opens up new avenues of treatment options focused on repair and regeneration that didn't exist before." Dr. Sadiq added, "We are delighted that the ICMS has approved our study and feel both the MSRCNY and the ICMS share the basic ideology of advancing safe and effective treatment in addressing patient needs."... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1405